Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Thomas Jefferson University
Washington University School of Medicine
BeiGene
Children's Oncology Group
Children's Oncology Group
Basilea Pharmaceutica
Massachusetts General Hospital
National Cancer Institute (NCI)
Canadian Cancer Trials Group
AbbVie
Children's Oncology Group
University of Michigan Rogel Cancer Center
AbbVie
Massachusetts General Hospital
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
University of Utah
Children's Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
NYU Langone Health
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)